UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 26 filers reported holding UNIQURE NV in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $740,000 | -35.3% | 100,448 | +4.3% | 0.06% | -44.2% |
| Q1 2016 | $1,144,000 | -72.1% | 96,279 | -61.1% | 0.10% | -71.9% |
| Q4 2015 | $4,098,000 | -23.8% | 247,783 | -5.8% | 0.37% | -28.4% |
| Q3 2015 | $5,379,000 | -3.1% | 263,011 | +27.9% | 0.52% | +0.8% |
| Q2 2015 | $5,550,000 | -6.0% | 205,572 | -15.3% | 0.51% | +1.0% |
| Q1 2015 | $5,902,000 | +507.8% | 242,717 | +270.3% | 0.51% | +366.1% |
| Q4 2014 | $971,000 | +286.9% | 65,544 | +141.3% | 0.11% | +220.6% |
| Q3 2014 | $251,000 | – | 27,166 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |